10 transactions in one company, from February 10, 2026 to May 15, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | VRTX | 10 | — | $3.0M |
10 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | May 15 | SPLAN | 33 | $453.45 | $15K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 25 | SPLAN | 620 | $486.35 | $302K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 24 | FPLAN | 582 | $485.11 | $282K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 18 | SPLAN | 1,182 | $473.68 | $560K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 17 | SPLAN | 2,437 | $489.46 | $1.2M |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 17 | FPLAN | 1,110 | $483.75 | $537K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 17 | APLAN | 2,584 | $0.00 | — |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 13 | F | 2,283 | $487.76 | $1.1M |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 11 | SPLAN | 2,021 | $460.43 | $931K |
| VERTEX PHARMACEUTICALS INC / MA | VRTX | Mark E. BunnageChief | Feb 10 | FPLAN | 1,127 | $468.41 | $528K |